Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series.

Jennifer G Le-RademacherKendrith RowlandPamela J AthertonChristopher DakhilZhifu SunAngelina TanLucy SchmidtPhuong L NguyenCarmen Radecki BreitkopfMark PittelkowDonald TindallSmitha MenonAminah Jatoi

Published in: The American journal of hospice & palliative care (2019)

Epidermal growth factor receptor inhibitor-induced rash appears to be androgen-mediated; antiandrogen therapy merits further study for rash prevention/palliation.

Keyphrases

epidermal growth factor receptor
tyrosine kinase
advanced non small cell lung cancer
high glucose
diabetic rats
climate change
small cell lung cancer
clinical trial
randomized controlled trial
study protocol
endothelial cells
stem cells
oxidative stress
social support